Which Billionaire Fund Manager Likes Horizon Pharma?

In a 13G filing last week, billionaire fund manager Thomas Steyer of Farallon Capital Management announced that his firm now had a 5.4% ownership stake in Horizon Pharma Inc.

Keep Reading →